KORU Medical seeks FDA clearance to expand FreedomEDGE into HER2+ breast cancer treatment
KORU Medical’s FDA filing to clear FreedomEDGE for PHESGO delivery could reshape cancer infusion workflows. Find out what it means for oncology care.
Medical Devices & Diagnostics
Pharma & Biotech
Corcept’s relacorilant CRL leaves endocrinology ambitions in limbo as oncology pivot takes center stage
Find out why FDA’s complete response letter for Corcept’s relacorilant could reshape treatment of hypercortisolism, with implications for oncology approval.
Pharma & Biotech
Can a global trials map help fix spondyloarthritis’s fragmented development landscape?
Explore what global spondyloarthritis trial trends in 2025 reveal about innovation gaps, sponsor risk, and regulatory hurdles. Read the full industry analysis.
Medical Devices & Diagnostics
Can Delcath’s HEPZATO redefine the treatment window for metastatic uveal melanoma?
New subgroup data on HEPZATO highlights improved survival in low-burden metastatic uveal melanoma. Find out what this changes in clinical strategy.
Pharma & Biotech
GSK strikes deal with U.S. to lower asthma and COPD drug prices and avoid tariffs
GSK plc’s latest agreement with the United States Administration to lower the price of respiratory medicines, including its inhaled asthma and chronic obstructive pulmonary disease (COPD) portfolio, signals a shift in how global pharmaceutical companies are choosing to respond to increasing U.S. political pressure around drug affordability. The agreement, announced on December 22, 2025, satisfies
Pharma & Biotech
What Purity Products UROX formula reveals about the future of urological wellness
A representative image depicting natural supplement capsules, reinforcing the rise of clinically formulated nutraceuticals like MyBladder® in urological wellness.
Pharma & Biotech
Could Vanda’s success with NEREUS revive interest in neurokinin-1 pathways?
NEREUS becomes first FDA-approved motion sickness drug in 40 years. Find out how this approval could reshape antiemetic strategies across industries.
Medical Devices & Diagnostics
Overture’s titanium implant sees rising use in patients too young for total knee replacement
Overture Orthopaedics hits $1M in sales for its knee resurfacing system targeting early OA. Find out what this milestone reveals about joint preservation.
Medical Devices & Diagnostics
What Lumos Infinitas’ CES showcase reveals about the next wave of physiological sensing
Find out how Lumos Infinitas’ photonics platform could shift clinical sensing and where adoption hurdles remain. Read analysis and expert insight.
Pharma & Biotech
Can Mabwell’s anti-IL-11 antibody redefine scarring treatment through fibrosis reversal?
Mabwell doses first patient in Phase II trial of IL-11 antibody for pathological scarring. Find out what this means for fibrosis drug development.